We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 198,696 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/9/2018 08:50 | nobby It's not too bad on advfn, only about 5-10 lunatics, try the LSE for the real deal. | dave4545 | |
20/9/2018 08:49 | On paper as I bought at 3.7p. Ok? There are some strange people on here.... | nobbygnome | |
20/9/2018 08:46 | how have you made money then nobby ? !! | arab3 | |
20/9/2018 08:45 | I was the only poster who pointed out ken chung was optimistic and gave a sub 5p prediction. | escapetohome | |
20/9/2018 08:45 | Lemmings only now.A short of the highest order.Completely worthless. | ken chung | |
20/9/2018 08:44 | I imagine Hugh will be too busy day trading to make an appearance here today!!! | eddie_yates | |
20/9/2018 08:39 | It's 3.7p v 4.2p, best bid/ask. 15k v 25k .... weak at the bid f | fillipe | |
20/9/2018 08:37 | Worthless lifestyle business.Avoid, avoid, avoid. | ken chung | |
20/9/2018 08:32 | Don't know as I haven't tried. | nobbygnome | |
20/9/2018 08:28 | can you sell nobby ? | arab3 | |
20/9/2018 08:21 | Making money already.... | nobbygnome | |
20/9/2018 08:18 | Probably a dcb at some point but longterm a dodo | volsung | |
20/9/2018 08:18 | Typical mm scam They crash the price and allow all sellers to bail out at the low but online to buy they offer nothing, nothing at all. They will put the price back to 4.5p and then let people buy thus making a fortune on all the stock they bought below 3.5p I'm not touching this above 4p | dave4545 | |
20/9/2018 08:17 | Ken Chung is now classified as a ramper.. 5p??! | dplewis1 | |
20/9/2018 08:16 | Probably run out of money in 6 months time. So will need a fundraise before then - imo. "...the Company maintains sufficient funds to continue to invest in undertaking the required work on Nuvec(R) well into 2019." | someuwin | |
20/9/2018 08:13 | I have bought a few more by spread bet! | nobbygnome | |
20/9/2018 08:10 | Pointless including the cash as that will be spent but yes there probably is value now. Plus the reduction in spend means there will probably mean there will not be a cash call now. Hmmmm | nobbygnome | |
20/9/2018 07:55 | Nobby Assuming cash is £1.5 mil now or slightly lower Nuvec is valued at £3.5 mil after the drop, do you see that as value ? | dave4545 | |
20/9/2018 07:36 | Interesting what the price will do today. Although clearly it has become more risky overnight as it is a one trick pony, the cash consumption will dramatically reduce which has to be good news.....and certainly dropping sildenafil is a good decision I was calling for. However, I am slightly surprised that the problem was so bad that the whole generics portfolio had to go. Probably down but maybe ultimately up..... | nobbygnome | |
20/9/2018 07:32 | We now ARE a one trick pony! | jimbobaroony | |
20/9/2018 07:20 | I'm sure you'll get a full apology and acknowledgement that he underestimated the risks.. ahem.. | dplewis1 | |
20/9/2018 07:14 | Yes it was on the cards . Let’s see what nuvec brings . No point selling now ... | jakleeds | |
20/9/2018 07:13 | I wonder if hugh will put in an appearance today. I think my views on the sildenafil reformulation and wider on the company have been completely vindicated. As usual it was all so predictable........u | nobbygnome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions